Tristel plc (R1V.F)
- Previous Close
4.8400 - Open
4.8400 - Bid 4.6200 x --
- Ask 4.8600 x --
- Day's Range
4.6200 - 4.8400 - 52 Week Range
3.0400 - 5.9000 - Volume
120 - Avg. Volume
52 - Market Cap (intraday)
223.067M - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
30.80 - EPS (TTM)
0.1500 - Earnings Date Feb 24, 2025
- Forward Dividend & Yield 0.17 (3.43%)
- Ex-Dividend Date Mar 20, 2025
- 1y Target Est
--
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems. The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
tristel.comRecent News: R1V.F
View MorePerformance Overview: R1V.F
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: R1V.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: R1V.F
View MoreValuation Measures
Market Cap
235.08M
Enterprise Value
228.21M
Trailing P/E
31.60
Forward P/E
20.79
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.45
Price/Book (mrq)
6.18
Enterprise Value/Revenue
4.41
Enterprise Value/EBITDA
18.62
Financial Highlights
Profitability and Income Statement
Profit Margin
14.09%
Return on Assets (ttm)
12.40%
Return on Equity (ttm)
19.61%
Revenue (ttm)
43.56M
Net Income Avi to Common (ttm)
6.14M
Diluted EPS (ttm)
0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
11.74M
Total Debt/Equity (mrq)
18.93%
Levered Free Cash Flow (ttm)
6.55M